Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $14.5K | $14.2K | $14.0K | $24.5K | $32.2K | $29.4K | $47.1K |
| Gross profit | $0 | −$14.5K | −$14.2K | −$14.0K | −$24.5K | −$32.2K | −$29.4K | −$47.1K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $238.7K | $327.4K | $806.8K | $2.2M | $2.1M | $1.7M | $2.0M |
| Operating income | −$98.6K | −$1.8M | −$1.5M | −$7.8M | −$4.2M | −$3.8M | −$3.4M | −$3.4M |
| EBITDA | −$98.1K | −$1.8M | −$1.5M | −$8.0M | −$4.5M | −$3.8M | −$3.4M | −$3.4M |
| Net income | −$402.8K | −$2.3M | −$1.5M | −$8.0M | −$4.5M | −$4.4M | −$11.5M | −$2.5M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -8.97 | -1.68 | -0.63 | -1.48 | -0.64 | -0.53 | -1.27 | -0.25 |
Annual figures · source: Financial Modeling Prep
IMAGIN MEDICAL INC
No one on the platform currently holds IMEXF.
No tracked institution reports a position in IMEXF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2020-10-27 | 1-for-20reverse |
| 2005-05-04 | 1-for-11reverse |
No one on the platform has traded IMEXF yet.
| $2795 |
| — |
| GBLXGB Sciences, Inc. | $0.00 | +33.33% | $162828 | — |
| NVOSNovo Integrated Sciences, Inc. | $0.00 | -77.14% | $15784 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.